Last reviewed · How we verify

NCT05346094

Cardiac Normal Values Assessed by Magnetic Resonance Imaging

Recruiting now Last updated 4 January 2023
What this trial tests

trial testing No intervention in Healthy Participants in 938 participants. Currently enrolling.

Timeline
1 January 2022
Primary endpoint
31 December 2026
30 June 2027

Quick facts

Lead sponsorChinese Academy of Medical Sciences, Fuwai Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment938
Start date1 January 2022
Primary completion31 December 2026
Estimated completion30 June 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital

Who can join

Under 80, any sex, with Healthy Participants or Reference Values. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study carried out a study enrolled healthy volunteers to comprehensively provide age and sex specific reference values of the normal cardiac structure and function of Chinese adults, using the steady-state free precession technique (SSFP) as well as reference values for novel cardiovascular magnetic resonance techniques including myocardial strian and tissue characterization.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Healthy Participants

Currently open trials in the same condition.

Other Chinese Academy of Medical Sciences, Fuwai Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05346094.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing